Identification of 2-Piperidone as a Biomarker of CYP2E1 Activity Through Metabolomic Phenotyping

Toxicological Sciences - United Kingdom
doi 10.1093/toxsci/kft143
Full Text
Abstract

Available in full text

Categories
Toxicology
Date
Authors
Publisher

Oxford University Press (OUP)

Related search

Thermochemistry of Some Derivatives of 2- And 4-Piperidone

English

Identification of CELSR2 as a Novel Prognostic Biomarker for Hepatocellular Carcinoma

BMC Cancer
Cancer ResearchOncologyGenetics
2020English

Obesity‐induced CYP2E1 Activity in Children

British Journal of Clinical Pharmacology
Pharmacology
2018English

Identification and Characterization of miR-96, a Potential Biomarker of NSCLC, Through Bioinformatic Analysis

Oncology Reports
MedicineCancer ResearchOncology
2017English

Induction of CYP2E1 Activity in Liver Transplant Patients as Measured by Chlorzoxazone 6-Hydroxylation*

Clinical Pharmacology and Therapeutics
Pharmacology
1998English

Identification of F5 as a Prognostic Biomarker in Patients With Gastric Cancer

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2020English

Anticancer Activity of an Imageable Curcuminoid 1-[2-Aminoethyl-(6-Hydrazinopyridine-3-Carbamidyl)-3,5-Bis-(2-Fluorobenzylidene)-4-Piperidone (EFAH)

Chemical Biology and Drug Design
BiochemistryOrganic ChemistryDrug DiscoveryMolecular MedicinePharmacology
2011English

Identification of P2P Flows Through Host Activity

2009English

Plasma Activity of Thioredoxin Reductase as a Novel Biomarker in Gastric Cancer

Scientific Reports
Multidisciplinary
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy